Clinical Trial Update: Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating belimumab for efficacy and safety in primary Sjögren's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sjögren's Syndrome | Phase 2 | Status: COMPLETED